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There is no routine support to prevent postpartum smoking relapse, due to lack of effective 
interventions. Previous reviews have identified behaviour change techniques (BCTs) within 
pregnancy cessation trials to specify which components might be incorporated into more 
effective interventions, but no reviews have identified BCTs for prevention of smoking 
relapse postpartum. We reviewed BCTs and potential delivery modes, to inform future 
interventions. 
Methods  
We searched Medline and EMBASE from January 2015- May 2017; and identified trials 
published before 2015 by handsearching systematic reviews. We included RCTs where: i) ≥1 
intervention component aimed to maintain smoking abstinence versus a less intensive 
intervention; ii) participants included pregnant or postpartum smoking quitters; iii) smoking 
status was reported in the postpartum period. We extracted trial characteristics and used the 
Behaviour Change Technique Taxonomy v1 to extract BCTs. We aimed to identity 
‘promising’ BCTs i.e. those frequently occurring and present in ≥2 trials that demonstrated 
long-term effectiveness (≥6 months postpartum). Data synthesis was narrative.  
Results 
We included 32 trials, six of which demonstrated long-term effectiveness. These six trials 
used self-help, mainly in conjunction with counselling, and were largely delivered remotely. 
















consequences’, ‘information about social and environmental consequences’, ‘social support’, 
‘reduce negative emotions’ and ‘instruction on how to perform a behaviour’. 
Conclusions 
Future interventions to prevent postpartum smoking relapse might include these six BCTs to 
maximise effectiveness. Tailored self-help approaches, with/without counselling, may be 
favourable modes of delivery of BCTs.  
Registration: PROSPERO CRD42018075677 
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Smoking in pregnancy or postpartum remains a major preventable cause of maternal and 
infant mortality and morbidity.1 Pregnancy acts as a strong motivator for smoking cessation, 
with more women quitting during pregnancy than at any other time in the life course. Indeed, 
it is estimated that up to 49% of women are able to ‘spontaneously quit’ before their first 
antenatal appointment2 due to factors such as maternal concerns for the health of the unborn 
baby.3,4 Pregnant women can be considered a particularly vulnerable population, since not 
only are they themselves at risk of harm from tobacco smoke, but there are also increased 
health risks to the developing fetus and to infants born to smoking mothers. Cessation 
















monitoring, are effective and cost effective ways to support pregnant smokers to quit.5 Most 
women who quit smoking during pregnancy wish to remain abstinent, but a high proportion 
return to smoking postpartum.2,6,7 Postpartum women are particularly vulnerable to smoking 
relapse due to factors such as perception of no longer needing to protect the baby, stress of 
dealing with a new infant, lack of confidence in remaining quit, nicotine dependence, living 
with a smoking partner, and a desire to return to their pre-pregnancy identity; act as 
contributors to relapse post-birth.3,4,8,9 Rates of return to smoking in the literature vary due to 
specific population characteristics and variation in success of any provided intervention.6,10 
Recent data estimates that up to 76% of spontaneous quitters restart smoking postpartum.6 
For women receiving cessation support; who may be more addicted or have weaker beliefs 
about the dangers of smoking; rates may be higher.2,6,7 In randomised clinical trials of 
within–pregnancy smoking cessation interventions, secondary analysis using point-
prevalence data estimated that across trials, the mean proportion of women smoking at the 
end of pregnancy was 87%, rising to 94% six months later, suggesting the majority of 
smoking cessation trial participants continue to smoke both throughout pregnancy and after 
childbirth.6  
Return to smoking postpartum has substantial health and cost implications, thus reducing 
exposure to smoke in pregnancy is an important goal worldwide.11 In the UK alone, the 
annual cost to the NHS of continuing to smoke in pregnancy is estimated to be as high as £64 
million for treating health related problems for mothers; and costs for treating mortality and 
morbidity of infants (aged 0-12 months) due to maternal smoking an estimated further £23.5 
million.12 Sustained smoking abstinence postpartum has significant health benefits for the 
mother and wider family due to reduced exposure to second hand smoke. Quitting smoking 
before the age of 30 avoids more than 97% of the excess mortality caused by smoking, due to 
















to second hand smoke have a higher incidence of sudden infant death, respiratory conditions 
including asthma, bronchitis and pneumonia, and other infections such as middle ear disease 
and meningitis.14 Furthermore, children of smoking mothers are twice as likely to become 
smokers themselves, perpetuating the cycle.15 The prevalence of smoking during pregnancy 
is higher in more disadvantaged groups2,16 and being less well educated has been identified as 
an important predictor of relapse postpartum.8 Despite these inequalities, health and cost 
implications; there is no routine provision of support to prevent relapse due to a lack of 
evidence-based interventions.17 There is thus a clear need to develop an effective intervention 
to prevent return to smoking in postpartum women.   
A number of interventions for relapse prevention in pregnancy and maintenance into the 
postpartum period have been developed; with modest success for those incorporating 
counselling, health education and/or financial incentives.2 Behavioural change interventions 
are complex in nature, consisting of multiple components designed to affect change.18 In 
order to describe active ingredients (components) of interventions, Michie and colleagues 
developed the Behaviour Change Technique Taxonomy v1 (BCTTv1).19,20 They propose that 
by identifying individual behaviour change techniques (BCTs) within interventions, it is 
possible to specify how interventions operate and therefore what components might be 
incorporated into new and more effective interventions.20 Other reviews have identified BCTs 
for a range of behaviour change interventions including smoking cessation support for 
general smokers21,22 and for smoking cessation in pregnancy23,24; but no reviews have 
identified BCTs for smoking relapse prevention in the postpartum period. We used the 
BCTTv1 taxonomy19 to identify BCT components which could be considered ‘promising, or 
likely to be effective in future interventions to maintain smoking abstinence postpartum. We 
















prevention interventions in order to understand how these ‘promising’ BCTs might be best 
delivered.   
 
Methods 
Types of trials 
We included randomised controlled trials of interventions where at least one component was 
designed to maintain smoking abstinence, versus a less intensive intervention or usual care. 
Participants were generally healthy pregnant or postpartum women who were recent smoking 
quitters (or a mixed population of recent quitters and smokers at baseline). Trials had to 
report smoking status (self-report or biochemically validated) in the postpartum period 
(beyond delivery). Trials not published in English were excluded due to the detailed 
intervention information required. Our review was registered on the PROSPERO 
international prospective register of systematic reviews (CRD42018075677).  
Searches 
We searched Medline and EMBASE from 1st January 2015 to 9th May 2017, to replicate and 
update the search strategy used by Jones and colleagues6 in a published systematic review of 
restarting smoking in the postpartum period. Keywords included: pregnancy, antenatal, 
prenatal, childbirth, postnatal, postpartum, breastfeeding, fetus, newborn, infant, tobacco, 
smoking, smoking cessation, and relapse. The full search strategy is published in Jones.6 
Randomised controlled trials published prior to 2015 were identified by handsearching Jones6 
and other recent pertinent systematic reviews of smoking cessation in pregnancy2,16 and 
















Selection of trials 
One author (TJB) screened citations on the basis of title and abstract, and also using tables of 
study characteristics when handsearching. A second reviewer (IG) independently screened 
10% of titles and abstracts for studies that appeared to be relevant to the review. 
Disagreement rate was not formally measured, but any disagreements were resolved by 
consensus. Where it was unclear if a study met our inclusion criteria, the full-text was 
collected and assessed. Each full-text article was assessed for inclusion using an 
inclusion/exclusion log. For excluded studies, the reason for exclusion was recorded at full-
text assessment.  
Data extraction 
We identified BCTs targeting smoking behaviour, i.e. BCTs included to maintain smoking 
abstinence, or to promote smoking cessation together with maintaining smoking abstinence. 
The BCTTv1 was used to extract BCTs by assigning BCT codes to appropriate sections of 
trial articles.19 Two researchers (TJB and CN) completed online training in BCTTv1 use 
(www.bct-taxonomy.com). To ensure consistency in data recording, data extraction of BCTs 
was duplicated independently at a level of 10%, with any disagreements resolved by 
discussion or the involvement of an expert third reviewer (WH) who co-authored the 
BCTTv1.19,20 To ensure any relevant BCTs were captured, we extracted BCTs whether they 
were definitely (coded ++) or probably (coded +) present, following BCTTv1 coding 
principles (www.bct-taxonomy.com). We calculated frequency of occurrence of BCTs across 
trials to define a list of ‘promising’ BCTs, most likely to be effective in relapse prevention 
interventions. We defined a BCT as ‘promising’ if it was present in at least two long-term 
effective interventions, as in Lorencatto24, and where frequency in all included trials, 
















long-term effective interventions as those finding statistically significant (p<0.05 where 
reported) differences in smoking abstinence between the intervention and control groups at 
six months postpartum or later (biochemically validated or self-report). The rationale for this 
two-pronged approach, was that by considering BCTs in light of their overall frequency, we 
might identify techniques most likely to be feasible, acceptable and fit for purpose.    
We also extracted data concerning characteristics of trial participants, details of the 
intervention and control, smoking status outcomes and data on intervention fidelity 
(adherence to the protocol, acceptability, compliance) in order to consider BCTs which might 
be most effective and suitable for postpartum relapse interventions and how these 
interventions might be best delivered. Data synthesis was narrative.  
 
Results 
Results of the search 
 
The inclusion of RCTs is summarised in Figure 1. Electronic searching identified 636 
records, 88 duplicate references were removed, resulting in 548 references for title and 
abstract screening.  From these records, 72 relevant full text articles were identified (48 
unique trials). Handsearching identified a further 69 relevant trials (after removal of 
duplicates). In total, articles from 117 studies were retrieved for full text assessment with the 
final inclusion of 32 primary RCTs (106 articles) which satisfied all inclusion criteria.25-130 
 
















The details of participants, intervention, comparison group, outcome measures, main findings 
and BCTs identified are described in Supplementary Table 1. The majority of studies (25 
trials) were conducted in the USA,25,26,34,36,57,64,66,75,83-86,88,89,94,98,99,101,106,111,113,116,118,124,128 two 
in Canada,55,80 two in the UK,67,129 and three elsewhere in Europe (Germany, Spain and 
Poland)68,79,95; all notably high income countries. Less than a third of interventions targeted 
lower socioeconomic groups or ethnic minorities.36,83,84,86,106,111,118,124,128,129    
Interventions were heterogeneous, differing in intervention content, mode of delivery, and 
population. Thirteen trials included mixed populations of pregnant smokers and quitters 
34,36,55,67,75,84,86,94,95,98,101,111,113; eleven included pregnant quitters26,57,64,66,83,99,106,116,118,124,128; 
two included mixed populations of postpartum smokers and quitters68,79; two included 
postpartum quitters25,80; three included pregnant women and partners85,89,129; and one included 
postpartum women and partners.88 Interventions in most trials (n=21) consisted of face-to-
face or telephone advice (counselling, cognitive behavioural therapy, motivational 
interviewing) plus additional support (mainly written self-help materials), with the remainder 
using: counselling alone36,116,118; self-help materials alone26,89,94,98; oral progesterone25,66; 
mobile phone alerts64; incentives plus counselling and supporting materials.84 Interventions 
were delivered by a wide range of clinical staff, pregnancy specialists, counsellors or 
researchers in either home or clinic settings. The intensity, duration, and time between 
intervention sessions varied widely from the provision of a single session to a maximum of 
14 sessions provided up to 9 months postpartum. Only two trials followed up participants 
beyond 12 months postpartum.68,116 We found no clear pattern as to which modes of delivery 
and timings of intervention contact would be best used to deliver intervention components 
















Smoking status was validated in at least a sample of the population at a particular time point 
in 26 trials, but six trials only used self-report data.55,64,68,83,95,129 Many trials reported some 
fidelity and/or acceptability issues, and we considered 10 trials as having reported major 
intervention fidelity and/or acceptability concerns,55,67,68,75,80,83,86,101,113,129 which may have 
influenced intervention effectiveness. These trials highlighted issues of low recruitment, low 
level of intervention implementation, low level of uptake of the intervention, or high dropout 
rates. There was no distinct pattern as to which specific components of interventions had 
been most affected by fidelity and/or acceptability, since this level of detail was often not 
reported. Some trials made no reference, or minor reference, to fidelity related issues 
suggesting there may also have been some underreporting of concerns relating to protocol 
adherence, acceptability, or compliance.  
Characteristics of long-term effective trials 
We found six long-term effective trials demonstrating a statistically significant difference in 
smoking abstinence between the intervention and control groups at six months postpartum or 
later.26,34,68,75,89,106. Five of these trials were conducted in the USA and one in Germany.68 
Three trials targeted abstinent pregnant women,26,89,106 one of which also included partners,89 
two trials targeted mixed populations of pregnant smokers and quitters34,75 and one trial 
included postpartum smokers and quitters.68  Four out of six interventions included an 
element of one-to-one counselling plus the provision of self-help materials, whilst two 
interventions26,89 provided only posted self-help educational materials. Control groups 
received a less intensive intervention or usual care. All long-term effective interventions took 
place in home settings and were largely delivered remotely (telephone calls, posted or 
emailed materials) using a variety of intensities and durations. Where counselling was 
















staff or by general trained counsellors. All but one of these trials68 reported some biochemical 
validation of outcome.  Two long-term effective trials68,75 reported intervention fidelity 
and/or acceptability concerns:  low adherence to motivational interviewing by trained 
counsellors68; or low levels of engaging women in smoking related issues in counselling 
calls.75 Had these issues not been present, it is possible that the intervention effect may have 
been stronger.   
Behaviour change techniques in trials and those characterised as ‘promising’ 
BCTs targeting improvements to smoking behaviour, that we identified from intervention 
descriptions in our included trials, are summarised in Table 1. BCTs for each individual trial 
are shown in Supplementary Table 1 (definitions of BCT codes are in Table 1). A total of 45 
of the 93 BCTs from the BCTTv1 were identified. The BCTTv1 organises 93 individual 
BCTs into 16 different groups according to similarity of individual BCT components.19 All 
groups were present in our included trials, with the exception of the group related to 
‘scheduled consequences’ (concerning punishments and costs versus rewards). The number 
of BCTs identified in individual interventions ranged from one to 19, with an average of 7.7 
BCTs per intervention. Focusing only on long-term effective interventions,26,34,68,75,89,106 the 
number of BCTs identified ranged from five to 19 with an average of 11 BCTs per 
intervention. The most prevalent BCTs in all includes trials (coded in ≥25% interventions) 
were: ‘problem solving ‘(n=27); ‘information about social and environmental consequences’ 
(n=27); ‘social support (unspecified)’ (n=25); ‘information about health consequences’ (n= 
18); ‘credible source’ (n=17); ‘instruction on how to perform a behaviour’ (n=11); and 
‘reduce negative emotions’ (n=9). For example, many trials gave information to participants 
















We characterised six BCTs as ‘promising’, or most likely to enhance effectiveness of 
interventions to maintain smoking abstinence. The BCTs which we identified as ‘promising’ 
were: ‘problem solving’ in all (i.e., 100%) of long-term effective interventions); ‘information 
about health consequences’ (100%); ‘information about social and environmental 
consequences’ (100%); ‘social support’ (100%); ‘reduce negative emotions’ (50%); and 
‘instruction on how to perform a behaviour’ (33%). If we were to remove the two trials68,75 
which reported fidelity and/or acceptability concerns in our analysis, these six BCTs would 
still meet our definition of ‘promising’, or most likely to be effective.  
 
Discussion 
This review is the first study, to our knowledge, to identify BCTs most promising for 
preventing postpartum smoking relapse. We identified a wide range of BCTs, finding an 
average of 7.7 BCTs per intervention for all included trials, and an average of 11 BCTs per 
intervention for long-term effective trials. There is a possibility that the effectiveness of 
interventions might be improved by incorporating more BCTs, implying more ‘complex’ 
interventions. We found six ‘promising’ BCTs, which were both frequently occurring and 
present in interventions that demonstrated long-term effectiveness of sustained smoking 
abstinence postpartum. These were: ‘problem solving’ which included advice on smoking 
relapse prevention; ‘information about health consequences’; ‘information about social and 
environmental consequences’ such as the effects of second-hand smoke; ‘social support’ 
from a partner or other supporter; ‘reduce negative emotions’ including stress management; 
and ‘instruction on how to perform a behaviour’ including skills training. Previous studies 
have identified effective BCTs using the smoking specific taxonomy22 for smoking cessation 
















superseded by the BCTTv1 designed for use in all behaviour change interventions.19 More 
recently, Campbell23 identified BCTs for smoking cessation in pregnancy based on 
combining the smoking specific taxonomy with the BCTTv1. However, they only included 
trials from a single Cochrane review.2 Our results concur with those of Campbell et al in 
finding the following BCTs to be potentially effective, based on their presence in two or more 
effective interventions: ‘information about consequences’; ‘problem solving’; ‘social support’ 
and ‘reduce negative emotions’. In total their review found 23 potentially effective 
techniques, but did not find the BCT ‘instruction on how to perform a behaviour’ to be 
present in effective interventions. However, providing advice on stop smoking medication 
and changing routine, have been identified as important BCTs for general smokers (smokers 
not necessarily pregnant or postpartum).21,22 Differences in our findings may be since these 
previous reviews were focused on smoking cessation, whilst we aimed to find BCTs effective 
for relapse prevention in the postpartum period.  
Pregnant and postpartum smokers tend to be of a lower socioeconomic status, less well 
educated and have lower levels of support.2,8 Future interventions and their BCT components 
need to be tailored to address the specific needs and cultural identity of these high-risk 
groups. Women who return to smoking postpartum may be less aware of the detrimental 
effects to the health of the baby caused by their return to smoking.8 This suggests the BCTs  
we identified concerning provision of ‘information about health consequences’ and 
‘information about social and environmental consequences’, would be fundamental to the 
success of an intervention to prevent postpartum smoking relapse. Having greater social or 
partner support is known to be a key facilitator to prevent relapse3,4,8 and our finding of the 
importance in providing enhanced social support is consistent with this. Only four trials 
included in this review specifically engaged with partner groups. A review of postpartum 
















wider social support network.10 We found BCTs prompting problem solving and providing 
guidance on how to maintain smoking abstinence to be ‘promising’, corresponding well with 
literature finding predictors for relapse include having a lower confidence to remain abstinent 
postpartum.8 Other predictors for relapse are experiencing higher levels of stress, depression 
and anxiety, and women who smoke are more likely to use substances in response to these 
circumstances.2,8 Our finding of the importance in including the BCT to ‘reduce negative 
emotions’ might therefore improve the chances of success of an intervention to maintain 
smoking abstinence. 
Many factors influence the effectiveness of BCTs within interventions in addition to the 
content; including intervention fidelity, acceptability, the mode of delivery, setting, duration, 
intensity and characteristics of the provider.24,131 Considering all of our included trials, we 
found no clear pattern relating these characteristics to the effectiveness of BCTs although, as 
noted by others, descriptions of intervention characteristics and fidelity related issues were 
limited in published papers.131 Long-term effective interventions that we identified all 
provided self-help support, and four out of six long-term effective trials combined self-help 
with counselling. For continued smoking abstinence postpartum, Chamberlain2 found some 
evidence for positive effects of health education, counselling and incentives. For smoking 
cessation in pregnancy, self-help interventions, including those delivered digitally (by 
computer or as text messages), have been found to be effective.132,133 Self-help provided as 
written or electronic support, or as part of counselling, may be favourable modes of delivery 
for BCTs and worthy of further research.  Long-term effective interventions included in this 
study were delivered in home settings and mostly delivered remotely (telephone calls, posted 
or emailed materials). This suggests effective interventions might be delivered relatively cost-
effectively. However, fidelity issues relating to protocol adherence, poor acceptability or 
















intervention effectiveness. Future interventions need to consider issues of implementation 
and acceptability in this population, who may be challenging to engage.  
Potential limitations to this review included the heterogeneity of participants, types of 
interventions and outcomes. Therefore, as in similar BCT content reviews,23,24 we did not 
attempt meta-analysis. As noted elsewhere in the literature,131 the level of detail needed for 
BCT coding was often not present in published intervention descriptions. In practice, 
interventions may have used more BCTs than those reported. We did not contact study 
authors, but did address this by taking an inclusive approach in our coding, including BCTs 
coded as probably present (+) in addition to those coded as definitely (++) present (www.bct-
taxonomy.com). We included a second independent coder for 10% of data extraction and 
involved a third reviewer where necessary to resolve discrepancies and to ensure any relevant 
BCTs had been correctly identified. Unfortunately we were unable to fully duplicate 
screening and data extraction due to limited resources. We did not assess risk of bias, as our 
main aim was to identify any potentially relevant BCTs, but we did describe any reported 
fidelity and/or acceptability issues, to consider how BCTs might be best delivered. As in 
other reviews23 we did not compare BCTs within effective and non-effective interventions. 
No trials reported a negative intervention effect and using this approach may have limited the 
number of potentially relevant BCTs. Measures of study effectiveness are also acknowledged 
to be ambiguous, since statistical significance is dependent on a wide range of factors, such 
as sample size.134  We cannot say with certainty that the presence of individual BCTs, 
demonstrates any causal relationship with trial outcome, but their repeated presence across 
long-term effective trials suggests they may be more promising approaches for future 
















Not all trials validated smoking abstinence biochemically, although a Cochrane review 
reported similar effect sizes in pregnancy trials which were validated and trials which were 
not.2 All trials were conducted in high-income countries with the majority conducted in the 
USA; which may mean findings would not be generalizable to other countries or contexts. 
Smoking in pregnancy is reducing in higher income countries but increasing in low and 
middle-income countries2,16 and no such countries met the inclusion criteria for this review. 
However, this may be since we excluded articles not published in English. The majority of 
included trials were targeted to general populations of pregnant or postpartum women, rather 
than populations of ethnic minorities or lower socioeconomic groups, where smoking 
prevalence is higher. Further research with these specific groups would be beneficial and 
might identify further relevant BCTs, such as BCTs concerning identity specific to different 
populations. Difficulty in adapting to a new mothering identity has been identified as a key 
factor in prompting return to smoking postpartum.3,4 We did not identify any trials that 
focused on nicotine replacement therapy (NRT) or were recent enough to include more novel 
approaches such as e-cigarettes. Evidence suggests that e-cigarettes are significantly less 
harmful than smoking tobacco and many smokers use e-cigarettes as an aid to quit.1,135 There 
is some evidence that for pharmacological interventions for smoking cessation in pregnancy, 
behavioural support in combination with NRT might be helpful.16  
Strengths to this review included the systematic approach to identifying relevant 
interventions and the application of the most recent behaviour change technique taxonomy.19 
We characterised BCTs as ‘promising’ if present in long-term effective interventions and 
where frequency in all included trials (regardless of effectiveness) was high. We were 
therefore able to consider ‘promising’ BCTs in light of their overall frequency in 
interventions relevant to this population, giving an indication of the ease by which these 
















acceptability. This is one of the first systematic reviews of BCTs specifically to prevent 
return to smoking postpartum and these results further our understanding of what behavioural 
support might be effective. Future research could compare interventions with different 
combinations of BCTs, or could compare BCTs in intervention and control groups. The 
identification and testing of BCTs in future postpartum relapse prevention interventions in a 
more diverse range of countries, with more diverse populations, and incorporating more 
novel components such as e-cigarettes would be beneficial to research and future practice. 
Identifying six specific BCTs as promising components for postpartum smoking relapse 
prevention highlights the need to customise support for this particular population. Further 
research by our team will explore these BCT components through qualitative research with 
postpartum ex-smokers in order to develop a prototype intervention for maintenance of 
smoking abstinence postpartum (MRC PHIND grant ref: MR/P016944/1). 
 
Conclusions 
We identified six promising BCTs to prevent postpartum smoking relapse based on a 
structured systematic review of published available evidence. Future interventions should 
consider the inclusion of BCTs addressing problem solving and how to maintain abstinent 
behaviour, information on health and other consequences of smoking, reducing negative 
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Table 1: Frequency of BCTs identified in smoking relapse interventions 
BCT 
code 









n (%); Max n=6 
1.1 Goal setting (behavior) 5 (16) 1 (17) 
1.2 Problem solving 27 (84) 6 (100)  * 
1.4 Action planning 1 (3) 0 (0) 
1.5 Review behavior goal(s) 4 (13) 0 (0) 
1.6 Discrepancy between current behavior and goal 1 (3) 1 (17) 
1.7 Review outcome goal(s) 2 (6) 0 (0) 
1.8 Behavioral contract 2 (6) 0 (0) 
1.9 Commitment 3 (9) 1 (17) 
2.2 Feedback on behavior 1 (3) 0 (0) 
2.3 Self-monitoring of behavior 3 (9) 0 (0) 
2.6 Biofeedback 4 (13) 0 (0) 
3.1 Social support (unspecified) 25 (78) 6 (100)  * 
3.2 Social support (practical) 3 (9) 1 (17) 
3.3 Social support (emotional) 3 (9) 1 (17) 
4.1 Instruction on how to perform a behavior 11 (34) 2 (33)   * 
4.2 Information about antecedents 2 (6) 0 (0) 
4.3 Re-attribution 1 (3) 1 (17) 
5.1 Information about health consequences 18 (56) 6 (100)  * 
5.3 Information about social and environmental consequences 27 (84) 6 (100)  * 
5.6 Information about emotional consequences 1 (3) 1 (17) 
6.1 Demonstration of the behavior 2 (6) 1 (17) 
6.2 Social comparison 4 (13) 3 (50) 
7.1 Prompts/cues 4 (13) 1 (17) 
8.1 Behavioral practice/ rehearsal 2 (6) 0 (0) 
8.2 Behavior substitution 5 (16) 2 (33) 
9.1 Credible source 17 (53) 1 (17) 
9.2 Pros and cons 7 (22) 3 (50) 
9.3 Comparative imagining of future outcomes 1 (3) 0 (0) 
10.1 Material incentive (behavior) 1 (3) 0 (0) 
10.2 Material reward (behavior) 1 (3) 0 (0) 
10.3 Non-specific reward 1 (3) 0 (0) 
10.4 Social reward 6 (19) 2 (33) 
10.7 Self-incentive 1 (3) 0 (0) 
11.1 Pharmacological support 3 (9) 1 (17) 
11.2 Reduce negative emotions 9 (28) 3 (50)   * 
12.1 Restructuring the physical environment 2 (6) 1 (17) 
12.2 Restructuring the social environment 2 (6) 1 (17) 
12.3 Avoidance/reducing exposure to cues for the behavior 4 (13) 2 (33) 
12.5 Adding objects to the environment 4 (13) 2 (33) 
13.1 Identification of self as role model 3 (9) 2 (33) 
13.2 Framing/reframing 7 (22) 2 (33) 
13.5 Identity associated with changed behavior 2 (6) 2 (33) 
15.1 Verbal persuasion about capability 7 (22) 1 (17) 
15.3 Focus on past success 1 (3) 1 (17) 
16.2 Imaginary reward 3 (9) 2 (33) 


































 First review of behaviour change techniques to prevent postpartum smoking relapse  
 Six promising behaviour change techniques (BCTs) were frequently coded 
 BCTs were problem solving, social support, information about consequences 
 How to perform a behaviour and reduce negative emotions were also promising BCTs 
ACCEPTED MANUSCRIPT
Figure 1
